Search

everythinglearnresearchcommunity

for

Search:↓

Rhodococcus equi causes severe pneumonia in young foals, and effective vaccines are needed due to foals' weak immune responses.

New treatments for a chronic skin condition show promise, but individualized plans are crucial due to varying responses.

Men are more likely to have severe respiratory viral infections like COVID-19 due to hormonal and genetic differences, while women generally have stronger immune responses.

Vitamin A affects hair loss and immune response in alopecia areata.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Females generally have stronger immune responses than males due to the X chromosome.

Androgens may influence T cells, contributing to higher autoimmune liver disease risk in women.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Nanotechnology can improve tissue healing by controlling immune responses.

IBD treatment is complex and requires personalized approaches due to varying patient responses.

The MATH+ protocol aims to improve COVID-19 outcomes using a combination of specific treatments.

Alopecia areata and vitiligo share immune system dysfunction but differ in specific immune responses and affected areas.

Topical JAK inhibitors can effectively treat alopecia areata and vitiligo by modulating immune responses.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Leptin, a hormone from fat cells, affects immune responses and can influence skin diseases and hair growth.

Type I interferons play a key role in the development of various skin diseases.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

NF-κB signaling is crucial in many diseases and can be targeted for new treatments.

New treatments and strategies are needed for Alopecia Areata, focusing on immune response and better trial designs.

Janus kinase inhibitors show promise in treating alopecia areata but need more safety research.

Targeting specific cell interactions may help treat skin fibrosis.

Alopecia areata may be treated by using EGCG to balance immune cells and reduce inflammation.

308-nm excimer light therapy helped over a third of treatment-resistant alopecia universalis patients regrow most of their hair.

Mesenchymal stem cells show promise in treating COVID-19 by reducing inflammation and aiding recovery, but more research is needed.

Ustekinumab might work for severe psoriasis, but more research is needed to be sure.

Deep skin fibroblasts help recruit immune cells for better wound healing.

Tofacitinib helps hair regrowth in alopecia areata but relapse is common after stopping treatment.

A new microneedle patch helps repair spinal cord injuries by reducing scarring and promoting nerve growth.

Baseline severity and relapse history affect alopecia areata treatment and recurrence.